Safety Study of BMS-770767 in Subjects With Type 2 Diabetes

NCT01046422 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Type 2

Interventions

DRUG: BMS-770767
DRUG: BMS-770767
DRUG: BMS-770767
DRUG: BMS-770767
DRUG: Placebo
DRUG: Metformin

Sponsor

Bristol-Myers Squibb